A randomised trial of accelerated radiotherapy for localised invasive bladder cancer

Radiotherapy and Oncology

Volumn 75, Issue 1, 2005, Pages 34-43

  Horwich, Alan ^a   Dearnaley, David ^a   Huddart, Robert ^a   Graham, John ^b   Bessell, Eric ^c   Mason, Malcolm ^d   Bliss, Judith ^e  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d VELINDRE CANCER CENTRE   (United Kingdom)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Accelerated fractionation; Bladder cancer; Radiotherapy; Randomised trial

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER INJURY; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; FEMALE; HUMAN; INTESTINE INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIATION INJURIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 18144406138     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.11.003     Document Type: Article

References (23)

1. G.J. Budgell, J.H. Mott, J.P. Logue, and A.R. Hounsell Clinical implementation of dynamic multileaf collimation for compensated bladder treatments Radiother Oncol 59 2001 31 38
2. The National Cancer Institute of Canada Clinical Trials Group C.M. Coppin, M.K. Gospodarowicz, and K. James Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation J Clin Oncol 14 1996 2901 2907
3. S. Dische, M. Saunders, and A. Barrett A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer Radiother Oncol 44 1997 123 136
4. R.F. Edsmyr, I. Anderson, and P.L. Esposti Irradiation therapy with multiple small fractions per day in urinary bladder cancer Radiother Oncol 4 1985 197 203
5. K. Fu, T.F. Pajak, and A. Trotti A Radiation Therapy Oncology Group 9RTOG phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Int. J Radiat Oncol Biol Phys 48 2000 7 16
6. L. Henningsohn, H. Wijkstrom, and P.W. Dickman Distressful symptoms after radical radiotherapy for urinary bladder cancer Radiother Oncol 62 2002 215 225
7. J.C. Horiot, P. Bontemps, and W. Van den Bogaert Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial Radiother Oncol 44 1997 111 121
8. A. Horwich, S. Pendlebury, and D.P. Dearnaley Organ conservation in bladder cancer (Abstr 1000) Eur J Cancer 31A 1995 S208
9. M. Hussain, T.R. Glass, and J. Forman Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study J Urol 165 2001 65 66 discussion 60-61
10. S. Hussain, D.D. Moffitt, and J.G. Glaholm A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer Ann Oncol 7 2001 929 935
11. International Collaboration of Trialists Neoadjuvant cisplatin. methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial Lancet 354 1999 533 540
12. K.M. Langen, and D.T. Jones Organ motion and its management Int J Radiat Oncol Biol Phys 50 2001 265 278
13. B. Maciejewski, and S. Majewski Dose fractionation and tumour repopulation in radiotherapy for bladder cancer Radiother Oncol 21 1991 163 170
14. M.D. Michaelson, W.U. Shipley, and N.M. Heney Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder Br J Cancer 90 2004 578 581
15. L. Moonen, H. Van der Voet, S. Horenblas, and H. Bartelink A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder Int J Radiat Oncol Biol Phys 37 1997 537 542
16. C. Rodel, G.G. Grabenbauer, and R. Kuhn Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results J Clin Oncol 20 2002 3061 3071
17. CHART Steering Committe M. Saunders, S. Dische, and A. Barrett Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial Lancet 350 1997 161 165
18. Shelley M, Barber J, Wilt T, Mason MD. Surgery versus radiotherapy for muscle invasive bladder cancer - Cochrane Database Syst Review 3 CD002079. Cochrane Database Syst Rev. 3 CD002079; 2001.
19. W.U. Shipley, D.S. Kaufman, and E. Zehr Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer Urology 60 2002 62 67
20. K.R. Trott, and J. Kummermehr What is known about tumour proliferation rates to choose between accelerated fractionation of hyperfractionation? Radiother Oncol 3 1985 1 9
21. International Union Against Cancer P. Hermanek L.H. Sobin UICC Internationale contre le Cancer, TNM Classification of malignant tumours 4th ed. 1987 Springer-Verlag Berlin
22. H. Withers The four R's of radiotherapy Adv Radiat Biol 5 1975 241 271
23. A. Zouhair, M. Ozsahin, and D. Schneider Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin Int J Cancer 96 2001 350 355